ED
MBLY

Exane Derivatives’s Mobileye N.V. MBLY Stock Holding History

Exane Derivatives’s Portfolio MBLY Stock Details MBLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-19
Closed -$1.19K – 670
2017
Q2 		$1.19K Sell
19
-105,873
-100% -$6.57M ﹤0.01% 464
2017
Q1 		$6.5M Buy
+105,892
New +$5.09M 1.47% 13

Other funds holding MBLY

BAM
Baring Asset Management London, United Kingdom $1.71B AUM 36.27% 1-Year Est. Return
GXMC
Global X Management Company New York $5.62B AUM 10.7% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
WAM
World Asset Management Detroit, Michigan $1.01B AUM 42.4% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return

Exane Derivatives's MBLY Position: Q3 2017 in Review

Exane Derivatives sold out of Mobileye N.V. (MBLY) in Q3 2017, closing a stake of 19 shares — an estimated $1.19K sold.

Exane Derivatives first reported a position in MBLY in Q1 2017 and held it in 2 quarters. The position peaked at $6.5M in Q1 2017. 30 funds tracked by Wall St. Rank hold MBLY as of Q3 2017.

  • Exane Derivatives reported no remaining Mobileye N.V. position as of Q3 2017 after selling out during the quarter.
  • Exane Derivatives sold 19 Mobileye N.V. shares in Q3 2017, an estimated $1.19K.
  • Exane Derivatives first reported a position in Mobileye N.V. in Q1 2017 and held it in 2 quarters.
  • Exane Derivatives's Mobileye N.V. position peaked at $6.5M in Q1 2017.
  • 30 funds tracked by Wall St. Rank held Mobileye N.V. as of Q3 2017.

Based on Exane Derivatives's 13F filing for Q3 2017, filed 18 Oct 2017.